Literature DB >> 15231591

Assessing the benefit-harm balance at the bedside.

Yoon Kong Loke1.   

Abstract

Mesh：

Year:  2004        PMID： 15231591      PMCID： PMC443429          DOI： 10.1136/bmj.329.7456.7

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Drug safety--important to us all!

Authors:  L E Böttiger
Journal:  J Intern Med       Date:  2001-10       Impact factor: 8.989

Review 2.  Assessment of therapeutic safety in systematic reviews: literature review.

Authors:  E Ernst; M H Pittler
Journal:  BMJ       Date:  2001-09-08

Review 3.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

4.  Benefits and harms of drug treatments.

Authors:  Jan P Vandenbroucke
Journal:  BMJ       Date:  2004-07-03

5.  Drug companies should report side effects in terms of frequency.

Authors:  R Bracchi
Journal:  BMJ       Date:  1996-02-17

6.  Provision of information about drug side-effects to patients.

Authors:  D C Berry; P Knapp; D K Raynor
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 7.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

8.  Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patient.

Authors:  Yoon Kong Loke; Alastair Bell; Sheena Derry
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

9.  An evidence based approach to individualising treatment.

Authors:  P P Glasziou; L M Irwig
Journal:  BMJ       Date:  1995-11-18

10.  Reporting of adverse drug reactions in randomised controlled trials - a systematic survey.

Authors:  Y K Loke; S Derry
Journal:  BMC Clin Pharmacol       Date:  2001-09-12
  10 in total
  7 in total

1.  Guest editorial.

Authors:  Andrew Herxheimer
Journal:  Health Expect       Date:  2005-12       Impact factor: 3.377

Review 2.  Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.

Authors:  Yoon Kong Loke; Deirdre Price; Sheena Derry; Jeffrey K Aronson
Journal:  BMJ       Date:  2006-01-18

Review 3.  A strategy for regulatory action when new adverse effects of a licensed product emerge.

Authors:  Jeffrey K Aronson; Deirdre Price; Robin E Ferner
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Search strategies to identify information on adverse effects: a systematic review.

Authors:  Su Golder; Yoon Loke
Journal:  J Med Libr Assoc       Date:  2009-04

5.  Communicating with patients about harms and risks.

Authors:  Andrew Herxheimer
Journal:  PLoS Med       Date:  2005-02-22       Impact factor: 11.069

Review 6.  Systematic reviews of adverse effects: framework for a structured approach.

Authors:  Yoon K Loke; Deirdre Price; Andrew Herxheimer
Journal:  BMC Med Res Methodol       Date:  2007-07-05       Impact factor: 4.615

Review 7.  Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogs.

Authors:  Marios Charalambous; Sara K Shivapour; David C Brodbelt; Holger A Volk
Journal:  BMC Vet Res       Date:  2016-05-21       Impact factor: 2.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.